APLS - Apellis Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$32.50
DETAILS
HIGH:
$41.00
LOW:
$24.00
MEDIAN:
$32.50
CONSENSUS:
$32.50
DOWNSIDE:
20.79%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Wood | 4,183,918 | $168.3M | 0.2% | +3,586,246 | INCREASED |
| Soros | 1,056,000 | $42.5M | 0.5% | +1,056,000 | NEW |
| Cooperman | 186,853 | $7.5M | 0.0% | +172,953 | INCREASED |
| Greenblatt | 78,750 | $3.2M | 0.0% | -89,705 | DECREASED |
| Dalio | 34,913 | $1.4M | 0.0% | -108,892 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-14 | Dunlop A. Sinclair | director | D-Return | 14,684 | $25.12 | $369K |
| 2026-05-14 | MELTZER LESLIE | officer: Chief Research and Development | D-Return | 92,592 | $27.93 | $2.6M |
| 2026-05-14 | MELTZER LESLIE | officer: Chief Research and Development | U-Tender | 107,024 | $4.00 | $428K |
| 2026-05-14 | Nicholson Nur | officer: Chief Technical Officer | D-Return | 28,367 | $66.30 | $1.9M |
| 2026-05-14 | Watson David O. | officer: General Counsel | D-Return | 38,250 | $44.33 | $1.7M |
| 2026-05-14 | Watson David O. | officer: General Counsel | D-Return | 37,708 | $52.66 | $2.0M |
| 2026-05-14 | Chopas James George | officer: VP/Chief Accounting Officer | A-Award | 16,150 | -- | -- |
| 2026-05-14 | Chopas James George | officer: VP/Chief Accounting Officer | A-Award | 8,075 | -- | -- |
| 2026-05-14 | Chopas James George | officer: VP/Chief Accounting Officer | A-Award | 5,625 | -- | -- |
| 2026-05-14 | Sullivan Timothy Eugene | officer: Chief Financial Officer | D-Return | 232,903 | $10.03 | $2.3M |
| 2026-05-14 | Machiels Alec | director | D-Return | 7,441 | $51.71 | $385K |
| 2026-05-14 | Machiels Alec | director | D-Return | 27,600 | $57.20 | $1.6M |
| 2026-05-14 | Deschatelets Pascal | officer: Chief Scientific Officer | A-Award | 12,920 | -- | -- |
| 2026-05-14 | Chan Gerald | director | D-Return | 27,600 | $57.20 | $1.6M |
| 2026-05-14 | DeLong Mark Jeffrey | officer: Chief Business & Strat Officer | U-Tender | 114,591 | $4.00 | $458K |
| 2026-05-14 | Watson David O. | officer: General Counsel | A-Award | 55,986 | -- | -- |
| 2026-05-14 | Watson David O. | officer: General Counsel | A-Award | 41,250 | -- | -- |
| 2026-05-14 | Watson David O. | officer: General Counsel | A-Award | 28,508 | -- | -- |
| 2026-05-14 | Watson David O. | officer: General Counsel | A-Award | 27,993 | -- | -- |
| 2026-05-14 | Watson David O. | officer: General Counsel | D-Return | 7,363 | -- | -- |
| 2026-05-14 | Francois Cedric | director, officer: Chief Executive Officer | A-Award | 97,976 | -- | -- |
| 2026-05-14 | Francois Cedric | director, officer: Chief Executive Officer | D-Return | 170,400 | $35.46 | $6.0M |
| 2026-05-14 | Francois Cedric | director, officer: Chief Executive Officer | D-Return | 150,000 | $44.90 | $6.7M |
| 2026-05-14 | Francois Cedric | director, officer: Chief Executive Officer | D-Return | 131,093 | $52.66 | $6.9M |
| 2026-05-14 | Baumal Caroline | officer: Chief Medical Officer | D-Return | 37,000 | $66.30 | $2.5M |